Intuitive Surgical Reports 21% Revenue Growth in Q2 2025 Despite Rising Costs and Challenges

Intuitive Surgical, Inc. (NASDAQ: ISRG) Financial Overview for Q2 2025

Current Developments:

• Intuitive Surgical has reported significant growth in revenue, with total revenue for Q2 2025 reaching $2.44 billion, up 21% from $2.01 billion in Q2 2024.
• Approximately 775,000 da Vinci procedures were performed in Q2 2025, reflecting a 17% increase compared to the same period last year.
• Ion procedures saw a remarkable growth of 52%, with approximately 35,300 procedures conducted in Q2 2025.
• Installed base of da Vinci surgical systems expanded to about 10,488 units, a 14% increase year-over-year.
• Da Vinci 5 system placements reached 180 units in Q2 2025, a significant rise from 70 units in Q2 2024.

Positive Aspects:

• Revenue from instruments and accessories increased by 18% to $1.47 billion in Q2 2025.
• Service revenue also rose by 23% to $391 million, driven largely by the expanding installed base of da Vinci surgical systems.
• Operating income improved by 31% year-over-year, totaling $743 million for Q2 2025.

Negative Aspects:

• Gross profit margin decreased from 68.3% in Q2 2024 to 66.3% in Q2 2025, primarily due to increased costs linked to the new da Vinci 5 system launch and tariffs.
• Higher operating expenses of $874.5 million represented 36% of revenue, compared to 40% the previous year, yet increased expenses still pressured profitability.
• Share-based compensation expenses increased, placing further pressure on operational costs, totaling $200 million for Q2 2025.

Key Statistics:

• Net income attributable to Intuitive Surgical was $658.4 million for Q2 2025, up from $526.9 million in Q2 2024.
• Total assets rose to $20.16 billion, compared to $18.74 billion as of December 31, 2024.
• Cash, cash equivalents, and investments increased to $9.53 billion as of June 30, 2025, from $8.83 billion the previous quarter.
• Operating cash flow was reported at $1.30 billion, higher than $885.9 million in the prior year's period.

The outlook for Intuitive Surgical shows resilience amid challenges such as increased operational costs due to market pressures and ongoing complexities from trade policies and tariffs. The company's ability to scale production and deploy innovative surgical solutions positions it well in the evolving healthcare landscape.